vatalanib has been researched along with Osteolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachelier, R; Clézardin, P; Confavreux, CB; Croset, M; Goehrig, D; Peyruchaud, O; van der Pluijm, G | 1 |
1 other study(ies) available for vatalanib and Osteolysis
Article | Year |
---|---|
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunocompromised Host; Mice; Mice, Inbred C3H; Osteolysis; Phthalazines; Pregnancy; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |